Skip to main content
Erschienen in: Supportive Care in Cancer 1/2014

01.01.2014 | Original Article

Oral status of patients submitted to autologous hematopoietic stem cell transplantation

verfasst von: Liana Leite Duval Fernandes, Sandra R. Torres, Marcia Garnica, Lucio de Souza Gonçalves, Arley Silva Junior, Álvaro Copello de Vasconcellos, Wellington Cavalcanti, Angelo Maiolino, Maria Cynésia Medeiros de Barros Torres

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Oral infection may be a source of bacteremia in patients undergoing hematopoietic stem cell transplant (HSCT). The aim of this study was to evaluate the relationship between patients with poor periodontal status and complications after HSCT.

Methods

A cohort of patients with hematological malignancies candidates for autologous HSCT was observed before and during the neutropenic phase of HSCT. A primary evaluation was performed before the HSCT procedure, including medical and socio-demographic data and physical examination (number of teeth and decayed, missing and filled teeth index (DMFT), oral mucosa, and full mouth periodontal assessment). During the neutropenic phase, data regarding the development of febrile neutropenia, bacteremia, and mucositis were also prospectively obtained.

Results

Forty-eight patients were included. The most common baseline disease was multiple myeloma (70 %). In the primary evaluations, the median DMFT was 13 (ranging 0–27), and periodontitis and gingivitis were present in 29 and 60 % of the patients, respectively. During the neutropenic phase of HSCT, fever occurred in 96 % of patients, and bacteremia was documented in 29 %. Coagulase-negative Staphylococcus was the most common isolated bacteria. Patients who developed bacteremia had a higher frequency of oral disorders compared with those without bacteremia, but it was not statistically significant. Oral mucositis affected 89.6 % of the patients, and patients with gingivitis or periodontal disorders had a high frequency of mucositis.

Conclusions

The prevalence of oral pathologic conditions previous to HSCT procedures was very high in the studied population. A possible association was noted between previous gingivitis and the development of mucositis during the neutropenia of HSCT.
Literatur
1.
Zurück zum Zitat Mullen CA, Nair J, Sandesh S, Chan KW (2000) Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplant 25:59–65PubMedCrossRef Mullen CA, Nair J, Sandesh S, Chan KW (2000) Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplant 25:59–65PubMedCrossRef
2.
Zurück zum Zitat Epstein JB, Raber-Durlacher JE, Wilkins A, Chavarria MG, Myint H (2009) Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:301–312PubMedCrossRef Epstein JB, Raber-Durlacher JE, Wilkins A, Chavarria MG, Myint H (2009) Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:301–312PubMedCrossRef
3.
Zurück zum Zitat Pattni R, Walsh LJ, Marshall RI, Cullinan MP, Seymour GJ, Bartold PM (2000) Changes in the periodontal status of patients undergoing bone marrow transplantation. J Periodontol 71:394–402PubMedCrossRef Pattni R, Walsh LJ, Marshall RI, Cullinan MP, Seymour GJ, Bartold PM (2000) Changes in the periodontal status of patients undergoing bone marrow transplantation. J Periodontol 71:394–402PubMedCrossRef
4.
Zurück zum Zitat Akintoye SO, Brennan MT, Graber CJ, McKinney BE, Rams TE, Barrett AJ, Atkinson JC (2002) A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:581–588PubMedCrossRef Akintoye SO, Brennan MT, Graber CJ, McKinney BE, Rams TE, Barrett AJ, Atkinson JC (2002) A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:581–588PubMedCrossRef
5.
Zurück zum Zitat Goldman KE (2006) Dental management of patients with bone marrow and solid organ transplantation. Dent Clin North Am 50:659–676, viii Goldman KE (2006) Dental management of patients with bone marrow and solid organ transplantation. Dent Clin North Am 50:659–676, viii
6.
Zurück zum Zitat Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831PubMedCrossRef Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831PubMedCrossRef
7.
Zurück zum Zitat Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, Maeda Y, Ishimaru F, Tanimoto M, Nishimura F, Takashiba S (2009) Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia. Support Care Cancer 17:581–587PubMedCrossRef Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, Maeda Y, Ishimaru F, Tanimoto M, Nishimura F, Takashiba S (2009) Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia. Support Care Cancer 17:581–587PubMedCrossRef
8.
Zurück zum Zitat Frere P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y (2004) Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 33:745–749PubMedCrossRef Frere P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y (2004) Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 33:745–749PubMedCrossRef
9.
Zurück zum Zitat Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B:93–97PubMedCrossRef Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B:93–97PubMedCrossRef
10.
Zurück zum Zitat Donker AE, van Merkesteyn JP, Bredius RG, van Weel-Sipman MH (2002) Value of panoramic radiographs in paediatric pre-bone marrow transplantation oral evaluation. Int J Oral Maxillofac Surg 31:170–172PubMedCrossRef Donker AE, van Merkesteyn JP, Bredius RG, van Weel-Sipman MH (2002) Value of panoramic radiographs in paediatric pre-bone marrow transplantation oral evaluation. Int J Oral Maxillofac Surg 31:170–172PubMedCrossRef
11.
Zurück zum Zitat Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T, Yoshida H (2006) A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant 38:237–242PubMedCrossRef Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T, Yoshida H (2006) A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant 38:237–242PubMedCrossRef
12.
Zurück zum Zitat Djuric M, Hillier-Kolarov V, Belic A, Jankovic L (2006) Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer 14:137–146PubMedCrossRef Djuric M, Hillier-Kolarov V, Belic A, Jankovic L (2006) Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer 14:137–146PubMedCrossRef
13.
Zurück zum Zitat Soga Y, Saito T, Nishimura F, Ishimaru F, Mineshiba J, Mineshiba F, Takaya H, Sato H, Kudo C, Kokeguchi S, Fujii N, Tanimoto M, Takashiba S (2008) Appearance of multidrug-resistant opportunistic bacteria on the gingiva during leukemia treatment. J Periodontol 79:181–186PubMedCrossRef Soga Y, Saito T, Nishimura F, Ishimaru F, Mineshiba J, Mineshiba F, Takaya H, Sato H, Kudo C, Kokeguchi S, Fujii N, Tanimoto M, Takashiba S (2008) Appearance of multidrug-resistant opportunistic bacteria on the gingiva during leukemia treatment. J Periodontol 79:181–186PubMedCrossRef
14.
Zurück zum Zitat Chen CY, Hansen KS, Hansen LK (2008) Rhizobium radiobacter as an opportunistic pathogen in central venous catheter-associated bloodstream infection: case report and review. J Hosp Infect 68:203–207PubMedCrossRef Chen CY, Hansen KS, Hansen LK (2008) Rhizobium radiobacter as an opportunistic pathogen in central venous catheter-associated bloodstream infection: case report and review. J Hosp Infect 68:203–207PubMedCrossRef
15.
Zurück zum Zitat Pion FLB, Araújo MWB, Feres M, Cortelli SC (2006) Periodontal status of a population subgroup from Guarulhos, SP. Revista Brasileira de Epidemiologia 9:335–345CrossRef Pion FLB, Araújo MWB, Feres M, Cortelli SC (2006) Periodontal status of a population subgroup from Guarulhos, SP. Revista Brasileira de Epidemiologia 9:335–345CrossRef
16.
Zurück zum Zitat Schaira V, Boer C, Basso F, Kellermann M, Correa ME (2009) Oral healthy characteristics and dental management of hematopoetic stem cell transplantation patients in a single public hospital. In Multinational Association for Supportive Care in Cancer (MASCC), pp. 164 Schaira V, Boer C, Basso F, Kellermann M, Correa ME (2009) Oral healthy characteristics and dental management of hematopoetic stem cell transplantation patients in a single public hospital. In Multinational Association for Supportive Care in Cancer (MASCC), pp. 164
17.
Zurück zum Zitat Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK (1992) Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 69:2469–2477PubMedCrossRef Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK (1992) Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 69:2469–2477PubMedCrossRef
18.
Zurück zum Zitat Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, Simoes BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M (2007) Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 39:775–781PubMedCrossRef Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, Simoes BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M (2007) Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 39:775–781PubMedCrossRef
19.
Zurück zum Zitat HIS— Immunocompromised Host Society (1990) The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel J Infect Dis 161:397–401 HIS— Immunocompromised Host Society (1990) The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel J Infect Dis 161:397–401
20.
Zurück zum Zitat NIH— National Institute of Health (1990) Consensus Development Panel. Consensus statement: oral complications of cancer therapies: diagnosis, prevention and treatment. NCI Monogr 9 NIH— National Institute of Health (1990) Consensus Development Panel. Consensus statement: oral complications of cancer therapies: diagnosis, prevention and treatment. NCI Monogr 9
21.
Zurück zum Zitat Ellegard B, Bergmann OJ, Ellegaard J (1989) Effect of plaque removal on patients with acute leukemia. J Oral Pathol Med 18:54–58CrossRef Ellegard B, Bergmann OJ, Ellegaard J (1989) Effect of plaque removal on patients with acute leukemia. J Oral Pathol Med 18:54–58CrossRef
22.
Zurück zum Zitat Graber CJ, de Almeida KN, Atkinson JC, Javaheri D, Fukuda CD, Gill VJ, Barrett AJ, Bennett JE (2001) Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27:537–542PubMedCrossRef Graber CJ, de Almeida KN, Atkinson JC, Javaheri D, Fukuda CD, Gill VJ, Barrett AJ, Bennett JE (2001) Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27:537–542PubMedCrossRef
23.
Zurück zum Zitat Elad S, Garfunkel AA, Or R, Michaeli E, Shapira MY, Galili D (2003) Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients. Support Care Cancer 11:674–677PubMedCrossRef Elad S, Garfunkel AA, Or R, Michaeli E, Shapira MY, Galili D (2003) Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients. Support Care Cancer 11:674–677PubMedCrossRef
24.
Zurück zum Zitat Barker GJ (1999) Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 7:17–20PubMedCrossRef Barker GJ (1999) Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 7:17–20PubMedCrossRef
25.
Zurück zum Zitat Barasch A (2000) Coke JM (2007) Cancer therapeutics: an update on its effects on oral health. Periodontol 44:44–54CrossRef Barasch A (2000) Coke JM (2007) Cancer therapeutics: an update on its effects on oral health. Periodontol 44:44–54CrossRef
26.
Zurück zum Zitat Blade J, Rosinol L (2009) Changing paradigms in the treatment of multiple myeloma. Haematologica 94:163–166PubMedCrossRef Blade J, Rosinol L (2009) Changing paradigms in the treatment of multiple myeloma. Haematologica 94:163–166PubMedCrossRef
27.
Zurück zum Zitat Wingard JR (2002) Antifungal chemoprophylaxis after blood and marrow transplantation. Clin Infect Dis 34:1386–1390PubMedCrossRef Wingard JR (2002) Antifungal chemoprophylaxis after blood and marrow transplantation. Clin Infect Dis 34:1386–1390PubMedCrossRef
28.
Zurück zum Zitat Heimdahl A, Mattsson T, Dahllof G, Lonnquist B, Ringden O (1989) The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 68:711–716PubMedCrossRef Heimdahl A, Mattsson T, Dahllof G, Lonnquist B, Ringden O (1989) The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 68:711–716PubMedCrossRef
29.
Zurück zum Zitat Epstein JB, Chow AW (1999) Oral complications associated with immunosuppression and cancer therapies. Infect Dis Clin North Am 13:901–923PubMedCrossRef Epstein JB, Chow AW (1999) Oral complications associated with immunosuppression and cancer therapies. Infect Dis Clin North Am 13:901–923PubMedCrossRef
30.
Zurück zum Zitat Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC (2008) Oral candidosis in community-based patients with advanced cancer. J Pain Symptom Manage 35:508–514PubMedCrossRef Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC (2008) Oral candidosis in community-based patients with advanced cancer. J Pain Symptom Manage 35:508–514PubMedCrossRef
31.
Zurück zum Zitat Pentenero M, Broccoletti R, Carbone M, Conrotto D, Gandolfo S (2008) The prevalence of oral mucosal lesions in adults from the Turin area. Oral Dis 14:356–366PubMedCrossRef Pentenero M, Broccoletti R, Carbone M, Conrotto D, Gandolfo S (2008) The prevalence of oral mucosal lesions in adults from the Turin area. Oral Dis 14:356–366PubMedCrossRef
32.
Zurück zum Zitat Santos PSS, Magalhães MHSG (2006) Oral mucositis evaluation in patients exposed to oral care procedures before bone marrow transplantation. RPG Rev Pos Grad 13:77–82 Santos PSS, Magalhães MHSG (2006) Oral mucositis evaluation in patients exposed to oral care procedures before bone marrow transplantation. RPG Rev Pos Grad 13:77–82
33.
Zurück zum Zitat Melkos AB, Massenkeil G, Arnold R, Reichart PA (2003) Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome. Clin Oral Investig 7:113–115PubMedCrossRef Melkos AB, Massenkeil G, Arnold R, Reichart PA (2003) Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome. Clin Oral Investig 7:113–115PubMedCrossRef
34.
Zurück zum Zitat Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026–2046PubMedCrossRef Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026–2046PubMedCrossRef
35.
Zurück zum Zitat Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27:525–529PubMedCrossRef Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27:525–529PubMedCrossRef
36.
Zurück zum Zitat Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374–377PubMedCrossRef Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374–377PubMedCrossRef
37.
Zurück zum Zitat Weikel DS, Peterson DE, Rubinstein LE, Metzger-Samuels C, Overholser CD Jr (1989) Incidence of fever following invasive oral interventions in the myelosuppressed cancer patient. Cancer Nurs 12:265–270PubMedCrossRef Weikel DS, Peterson DE, Rubinstein LE, Metzger-Samuels C, Overholser CD Jr (1989) Incidence of fever following invasive oral interventions in the myelosuppressed cancer patient. Cancer Nurs 12:265–270PubMedCrossRef
38.
Zurück zum Zitat Salazar R, Sola C, Maroto P, Tabernero JM, Brunet J, Verger G, Valenti V, Cancelas JA, Ojeda B, Mendoza L, Rodriguez M, Montesinos J, Lopez-Lopez JJ (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:27–33PubMedCrossRef Salazar R, Sola C, Maroto P, Tabernero JM, Brunet J, Verger G, Valenti V, Cancelas JA, Ojeda B, Mendoza L, Rodriguez M, Montesinos J, Lopez-Lopez JJ (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:27–33PubMedCrossRef
39.
Zurück zum Zitat Collin BA, Leather HL, Wingard JR, Ramphal R (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33:947–953PubMedCrossRef Collin BA, Leather HL, Wingard JR, Ramphal R (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33:947–953PubMedCrossRef
40.
Zurück zum Zitat Nucci M, Andrade F, Vigorito A, Trabasso P, Aranha JF, Maiolino A, De Souza CA (2003) Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 5:167–173PubMedCrossRef Nucci M, Andrade F, Vigorito A, Trabasso P, Aranha JF, Maiolino A, De Souza CA (2003) Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 5:167–173PubMedCrossRef
41.
Zurück zum Zitat Johnson GK, Slach NA (2001) Impact of tobacco use on periodontal status. Journal of Dental Education 65:313–321PubMed Johnson GK, Slach NA (2001) Impact of tobacco use on periodontal status. Journal of Dental Education 65:313–321PubMed
42.
Zurück zum Zitat Castillo JJ, Dhami PK, Curry S, Brennan K (2012) No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. American Journal of Hematology 87:729–731PubMedCrossRef Castillo JJ, Dhami PK, Curry S, Brennan K (2012) No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. American Journal of Hematology 87:729–731PubMedCrossRef
43.
Zurück zum Zitat Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foa R, Del Favero A (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. The New England Journal of Medicine 353:977–987PubMedCrossRef Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foa R, Del Favero A (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. The New England Journal of Medicine 353:977–987PubMedCrossRef
Metadaten
Titel
Oral status of patients submitted to autologous hematopoietic stem cell transplantation
verfasst von
Liana Leite Duval Fernandes
Sandra R. Torres
Marcia Garnica
Lucio de Souza Gonçalves
Arley Silva Junior
Álvaro Copello de Vasconcellos
Wellington Cavalcanti
Angelo Maiolino
Maria Cynésia Medeiros de Barros Torres
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1940-2

Weitere Artikel der Ausgabe 1/2014

Supportive Care in Cancer 1/2014 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.